Literature DB >> 14565900

Whipple disease.

Elan D Louis1.   

Abstract

Whipple disease is a rare disease caused by infection with the bacterium Tropheryma whippelii. Humans are the only known host for the infection. The signs of systemic infection include gastrointestinal problems, weight loss, and arthritis. Signs of central nervous system infection include cognitive changes, supranuclear gaze palsy, altered level of consciousness, and movement disorders. The diagnosis is based on clinical findings as well as microscopic examination of biopsy specimens and, more recently, polymerase chain reaction (PCR) analysis, which has high sensitivity and specificity. Although the organism historically has been difficult to culture, several recent attempts have been successful. Antibiotic treatment is recommended for 1 year while monitoring the clinical signs and cerebrospinal fluid PCR results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565900     DOI: 10.1007/s11910-003-0049-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  40 in total

1.  Relapsing Whipple's disease presenting with hypopituitarism.

Authors:  M Brändle; P Ammann; G A Spinas; F Dutly; R L Galeazzi; C Schmid; M Altwegg
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

2.  Whipple's disease--past, present, and future.

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

Review 3.  Whipple's disease and Tropheryma whippelii: secrets slowly revealed.

Authors:  M Maiwald; D Relman
Journal:  Clin Infect Dis       Date:  2001-01-18       Impact factor: 9.079

4.  Diagnosis and follow-up of Whipple's disease by amplification of the 16S rRNA gene of Tropheryma whippelii.

Authors:  B Pron; C Poyart; E Abachin; T Fest; C Belanger; C Bonnet; P Capelle; J F Bretagne; A Fabianek; L Girard; H Hagège; P Berche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-01       Impact factor: 3.267

5.  Whipple's disease confined to the CNS presenting with multiple intracerebral mass lesions.

Authors:  S J Wroe; M Pires; B Harding; B D Youl; S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

6.  Treatment of refractory Whipple disease with interferon-gamma.

Authors:  T Schneider; A Stallmach; A von Herbay; T Marth; W Strober; M Zeitz
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

7.  Synovial fluid polymerase chain reaction as an aid to the diagnosis of central nervous system Whipple's disease.

Authors:  N Delanty; L Georgescu; T Lynch; S Paget; J P Stübgen
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

8.  Intracerebral Whipple disease: unusual location and bone destruction. Case report.

Authors:  Ziya Akar; Necmettin Tanriover; Saffet Tüzgen; Bülent Canbaz; Haldun Erman; Buge Oz; Cengiz Kuday
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

9.  Tropheryma whippelii DNA in saliva of healthy people.

Authors:  S Street; H D Donoghue; G H Neild
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

10.  Cerebral Whipple's disease with a stroke-like presentation and cerebrovascular pathology.

Authors:  G Peters; D G du Plessis; P R Humphrey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

View more
  4 in total

1.  Whipple's disease presenting with neurological symptoms in an immunosuppressed patient.

Authors:  Martijn Weisfelt; Erik Oosterwerff; Mirjam Oosterwerff; Cees Verburgh
Journal:  BMJ Case Rep       Date:  2012-06-05

2.  Neurologic manifestations of Whipple's disease.

Authors:  Mara M Lugassy; Elan D Louis
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 3.  [Neurological complications of inflammatory bowel diseases].

Authors:  N Cieplik; M Stangel; O Bachmann
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 4.  Central ocular motor disorders, including gaze palsy and nystagmus.

Authors:  M Strupp; O Kremmyda; C Adamczyk; N Böttcher; C Muth; C W Yip; T Bremova
Journal:  J Neurol       Date:  2014-09       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.